Cargando…
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
Autores principales: | Tey, Siok-Keen, Lane, Steven W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905700/ https://www.ncbi.nlm.nih.gov/pubmed/34607349 http://dx.doi.org/10.1182/bloodadvances.2021004829 |
Ejemplares similares
-
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation
por: Deeg, H. Joachim
Publicado: (2022) -
New Threat at Doorstep: What an Intensivist should Know
por: Das, Akshaya Kumar, et al.
Publicado: (2022) -
Gender, hormone therapy, and HIV: what should cardiologists know?
por: Martinez, C. A., et al.
Publicado: (2019) -
Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation
por: Ullah, Md Ashik, et al.
Publicado: (2016) -
Transplant ureter should be stented routinely
por: Mongha, Ritesh, et al.
Publicado: (2010)